StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)

Close on Nov 17, 2026Market cap $947.51KP/E –Yield –

Oragenics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Oragenics's profit margin for the twelve months ending Dec 31, 2023 was -54858.1%. For fiscal 2023 it was -54858.1%, against -10864.0% the year before. The highest annual figure on record is -531.6% in fiscal 2011.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-54858.1%−43994.2
FY2022Dec 31, 2022-10864.0%+7198.1
FY2021Dec 31, 2021-18062.0%−17446.1
FY2014Dec 31, 2014-616.0%+940.7
FY2013Dec 31, 2013-1556.7%−573.8
FY2012Dec 31, 2012-982.9%−451.3
FY2011Dec 31, 2011-531.6%+64.7
FY2010Dec 31, 2010-596.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2023Sep 30, 2023-26960.7%−15149.5
Q2 FY2023Jun 30, 2023-23175.5%+7262.7
Q1 FY2023Mar 31, 2023-16710.7%–
Q3 FY2022Sep 30, 2022-4497.7%–
Q2 FY2022Jun 30, 2022-11811.2%–
Q1 FY2022Mar 31, 2022-30438.2%–

More Oragenics figures

See a number that looks wrong?